Flamma

Flamma Group is a family-owned, international CDMO with deep roots dating back to 1950, providing comprehensive small molecule API development and manufacturing services. It distinguishes itself through a unique tri-continental manufacturing footprint (Italy, USA, China), ensuring supply chain security and regulatory flexibility for its pharmaceutical clients. The company has received top industry awards, being recognized as a Top Performer in all core and specialty CDMO leadership categories. Its expertise spans custom synthesis, process optimization, and commercial production from kilo to multi-ton scale, with a particular strength in amino acid chemistry.

Integrated small molecule API development and manufacturing platform with specialized expertise in amino acid chemistry and protected derivatives (e.g., Fmoc-amino acids). Capabilities span custom synthesis, process R&D, scale-up, analytical development, and cGMP commercial manufacturing across owned facilities in Italy, USA, and China. Includes HPAPI and controlled substance handling capabilities.

Flamma competes in the fragmented but competitive global small molecule CDMO market. It differentiates itself through its family-owned, client-focused culture, award-winning service quality, and a strategic owned footprint in three key regions. Key competitors include large public CDMOs like Lonza, Catalent, and Cambrex, as well as other specialized private and regional players. Its niche strength in amino acid chemistry provides a specific competitive advantage in serving the peptide synthesis market.